Education
About Us
Working with TipRanks
Follow Us
The United Laboratories International (HK:3933)
:3933
RESEARCH TOOLSreports
3933 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$7.97 - HK$17.90
Previous CloseN/A
Volume6.42M
Average Volume (3M)12.31M
Market Cap
HK$27.40B
Enterprise ValueHK$20.67B
Total Cash (Recent Filing)HK$6.33B
Total Debt (Recent Filing)¥3.16B
Price to Earnings (P/E)9.7
Beta0.65
Next Earnings
Aug 21, 2025EPS Estimate
1.45Last Dividend Ex-Date
Jul 08, 2025Dividend Yield4.68%
Share Statistics
EPS (TTM)0.70
Shares Outstanding1,817,026,500
10 Day Avg. Volume11,302,389
30 Day Avg. Volume12,312,668
Financial Highlights & Ratios
PEG Ratio-1.02
Price to Book (P/B)1.66
Price to Sales (P/S)0.00
P/FCF Ratio22.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$17.03Price Target Upside10.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
The United Laboratories International Holdings News
PremiumCompany Announcements
The United Laboratories Announces Share Placement to Fund Expansion and R&D
PremiumCompany Announcements
United Laboratories’ Antibiotic Injection Passes Key Evaluation
PremiumCompany Announcements
FDA Approves United Laboratories’ Innovative Drug for Obesity
PremiumCompany Announcements
The United Laboratories Announces Final Dividend for 2024
PremiumCompany Announcements
The United Laboratories Announces Special Dividend for 2024
PremiumCompany Announcements
United Laboratories Announces 2024 Final and Special Dividends
PremiumCompany Announcements
United Laboratories’ AGM Resolutions Passed, Affirming Strategic Direction
PremiumCompany Announcements
United Laboratories Secures $180 Million Upfront Payment from Novo NordiskOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.98%
Mutual Funds
0.09% Other Institutional Investors
91.72% Public Companies and
Individual Investors
3933 FAQ
What was The United Laboratories International’s price range in the past 12 months?
The United Laboratories International lowest stock price was HK$7.97 and its highest was HK$17.90 in the past 12 months.
What is The United Laboratories International’s market cap?
The United Laboratories International’s market cap is HK$27.40B.
When is The United Laboratories International’s upcoming earnings report date?
The United Laboratories International’s upcoming earnings report date is Aug 21, 2025 which is in 33 days.
How were The United Laboratories International’s earnings last quarter?
The United Laboratories International released its earnings results on Mar 25, 2025. The company reported HK$0.699 earnings per share for the quarter, missing the consensus estimate of HK$0.852 by -HK$0.153.
Is The United Laboratories International overvalued?
According to Wall Street analysts The United Laboratories International’s price is currently Undervalued.
Does The United Laboratories International pay dividends?
The United Laboratories International pays a Notavailable dividend of HK$0.438 which represents an annual dividend yield of 4.68%. See more information on The United Laboratories International dividends here
What is The United Laboratories International’s EPS estimate?
The United Laboratories International’s EPS estimate is 1.45.
How many shares outstanding does The United Laboratories International have?
The United Laboratories International has 1,817,026,500 shares outstanding.
What happened to The United Laboratories International’s price movement after its last earnings report?
The United Laboratories International reported an EPS of HK$0.699 in its last earnings report, missing expectations of HK$0.852. Following the earnings report the stock price went down -11.78%.
Which hedge fund is a major shareholder of The United Laboratories International?
Currently, no hedge funds are holding shares in HK:3933
The United Laboratories International Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$17.03 (10.76% Upside)
HK$17.03 (10.76% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.55%
12-Months-Change
Fundamentals
Return on Equity
19.62%
Trailing 12-Months
Asset Growth
19.43%
Trailing 12-Months
Company Description
The United Laboratories International
The United Laboratories International Holdings Limited (3933) is a prominent pharmaceutical company that engages in the research, development, manufacturing, and sale of a diverse range of pharmaceutical products. The company operates within the biopharmaceutical sector, focusing primarily on antibiotics, insulin products, and other therapeutic drugs. With a significant presence in China and an expanding footprint in international markets, The United Laboratories is committed to providing high-quality healthcare solutions and enhancing patient care globally.
Technical Analysis
Grand Pharmaceutical Group Limited
―
HUTCHMED (China)
―
China Resources Pharmaceutical Group Ltd.
―
Livzon Pharmaceutical Group
―
China Medical System Holdings
―